Emeis (EMEIS.PA) Stock Price

Emeis Price

Euronext·CLOSED
14.41EUR+0.14 (+0.98 %)
Market closed

Revenue has compounded at 15.0% per year over the past 19 years to 5.90 B EUR. Earnings per share have grown at 38.0% per year over the last 17 years. Emeis's net margin stands at -5.1%, down from 1.5% several years earlier. Emeis currently offers a dividend yield of about 6.25%. The dividend has grown at 20.1% per year over the past 12 years. Analysts set a median price target of 15.81 EUR, implying 9.7% above the current price. Of 12 analysts, 2 rate the stock a buy — an overall Sell consensus. The stock trades about 34% above its 52-week low.

Emeis stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Emeis over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Emeis stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Emeis's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Emeis Stock Price History
DateEmeis Price
8/6/202614.41 EUR
8/5/202614.27 EUR
8/4/202614.20 EUR
7/31/202614.56 EUR
7/30/202614.43 EUR
7/29/202613.92 EUR
7/28/202613.58 EUR
7/27/202613.72 EUR
7/24/202613.77 EUR
7/23/202613.87 EUR
7/22/202613.96 EUR
7/21/202613.88 EUR
7/20/202613.85 EUR
7/17/202614.04 EUR
7/16/202614.25 EUR
7/15/202614.25 EUR
7/14/202614.22 EUR
7/13/202613.92 EUR
7/10/202613.96 EUR
7/9/202614.11 EUR
7/8/202614.27 EUR
7/7/202614.31 EUR
7/6/202614.57 EUR
7/3/202614.69 EUR
7/2/202614.59 EUR
7/1/202614.62 EUR
6/30/202614.05 EUR
6/29/202613.82 EUR
6/26/202614.50 EUR
6/25/202614.32 EUR
6/24/202613.96 EUR
6/23/202614.00 EUR
6/22/202614.05 EUR
6/19/202614.12 EUR
6/18/202613.50 EUR
6/17/202613.63 EUR
6/16/202613.73 EUR
6/15/202614.37 EUR
6/12/202613.97 EUR
6/11/202613.95 EUR
6/10/202613.92 EUR
6/9/202614.01 EUR
6/8/202614.28 EUR
6/5/202614.13 EUR
6/4/202614.09 EUR
6/3/202614.11 EUR
6/2/202614.43 EUR
6/1/202614.82 EUR
5/29/202615.22 EUR
5/28/202614.99 EUR
5/27/202615.00 EUR
5/26/202614.87 EUR
5/25/202615.07 EUR
5/22/202614.57 EUR
5/21/202614.71 EUR
5/20/202614.63 EUR
5/19/202614.57 EUR
5/18/202614.74 EUR
5/15/202615.14 EUR
5/14/202615.33 EUR
5/13/202614.74 EUR
5/12/202614.41 EUR
5/11/202614.65 EUR
5/8/202615.13 EUR
5/7/202615.18 EUR
5/6/202615.29 EUR
5/5/202615.01 EUR
5/4/202614.42 EUR
4/30/202614.33 EUR
4/29/202614.37 EUR
4/28/202614.60 EUR
4/27/202614.73 EUR
4/24/202614.26 EUR
4/23/202614.16 EUR
4/22/202613.83 EUR
4/21/202613.73 EUR
4/20/202613.71 EUR
4/17/202614.01 EUR
4/16/202613.91 EUR
4/15/202613.70 EUR
4/14/202613.39 EUR
4/13/202613.47 EUR
4/10/202613.65 EUR
4/9/202613.81 EUR
4/8/202615.06 EUR
4/7/202614.32 EUR
4/2/202613.56 EUR
3/27/202612.27 EUR
3/26/202612.34 EUR
3/25/202612.99 EUR
3/24/202613.08 EUR
3/23/202613.56 EUR
3/20/202613.44 EUR
3/19/202613.93 EUR
3/17/202613.77 EUR
3/16/202613.94 EUR
3/13/202613.94 EUR
3/12/202613.96 EUR
3/11/202614.34 EUR
3/10/202614.57 EUR
3/9/202613.83 EUR
3/6/202614.00 EUR
3/5/202613.93 EUR
2/27/202615.15 EUR
2/26/202614.74 EUR
2/25/202613.99 EUR
2/23/202614.68 EUR
2/20/202614.03 EUR
2/19/202613.99 EUR
2/18/202614.91 EUR
2/17/202615.18 EUR
2/16/202614.60 EUR
2/13/202614.68 EUR
2/12/202614.77 EUR
2/11/202614.89 EUR
2/10/202614.79 EUR
2/9/202614.46 EUR
2/6/202614.14 EUR
2/5/202614.38 EUR
2/4/202614.27 EUR
2/3/202613.96 EUR
2/2/202614.20 EUR
1/30/202613.62 EUR
1/29/202613.55 EUR
1/28/202614.20 EUR
1/27/202614.33 EUR
1/26/202613.97 EUR
1/23/202613.71 EUR
1/22/202613.97 EUR
1/21/202613.62 EUR
1/20/202613.63 EUR
1/19/202613.49 EUR
1/16/202613.50 EUR
1/15/202614.12 EUR
1/14/202614.59 EUR
1/13/202614.13 EUR
1/12/202614.18 EUR
1/9/202614.64 EUR
1/8/202614.62 EUR
1/7/202614.15 EUR
1/6/202613.69 EUR
1/5/202614.02 EUR
1/2/202614.62 EUR
12/31/202514.33 EUR
12/30/202514.46 EUR
12/29/202513.83 EUR
12/24/202513.70 EUR
12/23/202513.93 EUR
12/22/202513.93 EUR
12/19/202513.37 EUR
12/18/202512.53 EUR
12/17/202512.39 EUR
12/16/202512.72 EUR
12/15/202513.12 EUR
12/12/202513.01 EUR
12/11/202513.30 EUR
12/10/202514.14 EUR
12/9/202514.10 EUR
12/8/202514.20 EUR
12/5/202513.28 EUR
12/4/202513.26 EUR
12/3/202513.36 EUR
12/2/202513.40 EUR
12/1/202513.31 EUR
11/28/202513.37 EUR
11/27/202513.43 EUR
11/26/202513.19 EUR
11/25/202513.24 EUR
11/24/202513.36 EUR
11/21/202513.05 EUR
11/20/202512.90 EUR
11/19/202513.01 EUR
11/18/202513.32 EUR
11/17/202513.22 EUR
11/14/202513.47 EUR
11/13/202513.68 EUR
11/12/202513.55 EUR
11/11/202514.01 EUR
11/10/202514.25 EUR
11/7/202512.84 EUR
11/6/202513.10 EUR
11/5/202513.30 EUR
11/4/202513.63 EUR
11/3/202513.70 EUR
10/31/202514.31 EUR
10/30/202514.58 EUR
10/29/202515.71 EUR
10/28/202514.37 EUR
10/27/202514.62 EUR
10/24/202514.36 EUR
10/23/202514.00 EUR
10/22/202513.64 EUR
10/21/202513.84 EUR
10/20/202514.13 EUR
10/17/202514.49 EUR
10/16/202514.64 EUR
10/15/202515.07 EUR
10/14/202515.30 EUR
10/13/202515.19 EUR
10/10/202515.00 EUR
10/9/202515.51 EUR
10/8/202514.57 EUR
10/7/202514.24 EUR
10/6/202513.82 EUR
10/3/202514.70 EUR
10/2/202514.61 EUR
10/1/202514.84 EUR
9/30/202514.76 EUR
9/29/202514.00 EUR
9/26/202513.55 EUR
9/25/202513.57 EUR
9/24/202513.39 EUR
9/23/202512.15 EUR
9/22/202512.26 EUR
9/19/202512.51 EUR
9/18/202512.07 EUR
9/17/202511.86 EUR
9/16/202512.06 EUR
9/15/202512.03 EUR
9/12/202512.00 EUR
9/11/202512.04 EUR
9/10/202511.61 EUR
9/9/202511.08 EUR
9/8/202510.75 EUR
9/5/202511.00 EUR
9/4/202511.17 EUR
9/3/202510.96 EUR
9/2/202511.34 EUR
9/1/202511.86 EUR
8/29/202512.21 EUR
8/28/202512.44 EUR
8/27/202512.77 EUR
8/26/202513.00 EUR
8/25/202514.20 EUR
8/22/202514.97 EUR
8/21/202514.85 EUR
8/20/202514.24 EUR
8/19/202514.13 EUR
8/18/202514.24 EUR
8/15/202513.97 EUR
8/14/202513.61 EUR
8/13/202513.17 EUR
8/12/202513.40 EUR
8/11/202513.46 EUR
Access this data via the Eulerpool API
Get Free API Key

Emeis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
5.20 B EUR
-918.73 M EUR
1.35 B EUR
Jan 1, 2024
5.64 B EUR
-38.20 M EUR
-412.07 M EUR
Jan 1, 2025
5.90 B EUR
173.25 M EUR
-298.40 M EUR
Jan 1, 2026 (e)
6.15 B EUR
-471.86 M EUR
-99.29 M EUR
Jan 1, 2027 (e)
6.38 B EUR
-492.03 M EUR
32.29 M EUR
Jan 1, 2028 (e)
6.58 B EUR
-510.93 M EUR
55.95 M EUR
Jan 1, 2029 (e)
6.76 B EUR
-525.30 M EUR
308.35 M EUR
Jan 1, 2030 (e)
6.94 B EUR
-539.43 M EUR
387.46 M EUR

Emeis Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 8:08 PM
 
REVENUEB EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEB EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
2.392.843.143.423.743.924.304.685.205.645.906.156.386.586.766.94
22.7418.8210.458.959.394.879.598.8911.058.434.614.333.673.152.812.69
19.9119.5720.3020.5027.8924.5521.4515.2412.6080.0280.7680.7680.7680.7680.7680.76
0.480.560.640.701.040.960.920.710.664.514.764.975.155.315.465.61
303.00348.00394.00427.00503.00422.00395.00-49.00-918.00-38.00173.00-471.00-492.00-510.00-525.00-539.00
12.6712.2512.5612.4913.4510.769.19-1.05-17.66-0.672.93-7.66-7.72-7.75-7.76-7.76
0.130.290.090.220.230.160.07-4.031.35-0.41-0.30-0.100.030.060.310.39
5.00132.54-69.62147.195.91-31.33-59.38-6,295.38-133.62-130.43-27.67-66.78-132.3271.88460.0025.65
0.800.901.001.101.20–0.90––––58.8560.2561.69––
14.2912.5011.1110.009.09–––––––2.382.39––
60.2560.2462.6064.6068.4771.4064.5764.63114.32164.02161.10161.10161.10161.10161.10161.10
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Emeis generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Emeis retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Emeis's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Emeis has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Emeis's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Emeis stock margins

The Emeis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Emeis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Emeis.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
21.46 %
9.21 %
1.52 %
Jan 1, 2022
15.25 %
-1.05 %
-86.03 %
Jan 1, 2023
12.62 %
-17.68 %
26.07 %
Jan 1, 2024
80.01 %
-0.68 %
-7.31 %
Jan 1, 2025
80.76 %
2.94 %
-5.06 %
Jan 1, 2026 (e)
80.76 %
-7.67 %
-1.61 %
Jan 1, 2027 (e)
80.76 %
-7.72 %
0.51 %
Jan 1, 2028 (e)
80.76 %
-7.77 %
0.85 %

Emeis Stock Revenue, EBIT, Earnings per Share

The Emeis earnings per share therefore indicates how much revenue Emeis has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
66.58 EUR
6.13 EUR
1.01 EUR
Jan 1, 2022
72.43 EUR
-0.76 EUR
-62.31 EUR
Jan 1, 2023
45.47 EUR
-8.04 EUR
11.85 EUR
Jan 1, 2024
34.36 EUR
-0.23 EUR
-2.51 EUR
Jan 1, 2025
36.59 EUR
1.08 EUR
-1.85 EUR
Jan 1, 2026 (e)
38.10 EUR
-2.93 EUR
-0.62 EUR
Jan 1, 2027 (e)
39.50 EUR
-3.05 EUR
0.20 EUR
Jan 1, 2028 (e)
40.74 EUR
-3.17 EUR
0.35 EUR

Emeis business model & stock analysis

Emeis Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Emeis historical P/E ratio, EBIT multiple, and P/S ratio

Emeis annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Emeis shares outstanding

The number of shares of Emeis was 161.1 M in 2025. This indicates how many shares Emeis is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
64.57 M Stocks
Jan 1, 2022
64.63 M Stocks
Jan 1, 2023
114.32 M Stocks
Jan 1, 2024
164.02 M Stocks
Jan 1, 2025
161.10 M Stocks
Jan 1, 2026 (e)
161.10 M Stocks
Jan 1, 2027 (e)
161.10 M Stocks
Jan 1, 2028 (e)
161.10 M Stocks

Emeis stock splits

In Emeis's history, there have been no stock splits.

Emeis Dividend History

12 years of dividend payments

YearAnnual DividendYoY ChangePayments
20210.90EUR↓ 25.0%1×
20191.20EUR↑ 9.1%1×
20181.10EUR↑ 10.0%1×
20171.00EUR↑ 11.1%1×
20160.90EUR↑ 12.5%1×
20150.80EUR↑ 14.3%1×
20140.70EUR↑ 16.7%1×
20130.60EUR↑ 20.0%1×
20120.50EUR↑ 117.4%1×
20110.23EUR↑ 53.3%1×

Emeis dividend payout ratio

In 2025, Emeis had a payout ratio of 4,195.18%. The payout ratio indicates the percentage of the company's profits that Emeis distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
5,693.10 %
Jan 1, 2022
3,755.73 %
Jan 1, 2023
4,260.14 %
Jan 1, 2024
4,569.66 %
Jan 1, 2025
4,195.18 %
Jan 1, 2026 (e)
4,341.66 %
Jan 1, 2027 (e)
30,125.21 %
Jan 1, 2028 (e)
17,798.65 %

Current Emeis forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
16.67 % (2)
Hold
33.33 % (4)
Sell
50.00 % (6)
12M Price Target
15.81
Last Price
14.41
Currency
EUR
12M Return Potential
9.72 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Emeis stock

70/100
77
Environment
76
Social
57
Governance
E

Environment

20
Scope 1 - Direct Emissions86,018
Scope 2 - Indirect emissions from purchased energy57,926
Scope 3 - Indirect emissions within the value chain501,482
Total CO₂ emissions143,944
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees45.45
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Emeis shareholder structure

% Name
2.81759%
Carmignac Gestion
Carmignac Gestion
0.54514%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.47087%
Moneta Asset Management
Moneta Asset Management
0.35803%
Niche Asset Management Limited
Niche Asset Management Limited
0.24191%
Charles Schwab Investment Management, Inc.
Charles Schwab Investment Management, Inc.
0.18630%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

Emeis Beneficial Ownership Filings (SEC 13D/G)

Free Float
62.9%
Float Shares
-
Shares Outstanding
-

Emeis Executives and Management Board

35 members · avg. age 60 · 46 % women

LG

Mr. Laurent Guillot (55)

Chief Executive Officer, Director · since 2022

1.37 M EUR

Management

JB

Mr. Jean-Marc Boursier

Deputy Chief Executive Officer, Chief Financial Officer, in charge of Central Europe and Latin America, Member of the Management Board

–
GL

Mr. Gotz Leschonsky

Chief Executive Officer, Germany

–
JW

Mr. Jayne William

Chief Executive Officer, England

–
FB

Ms. Fanny Barbier

Executive Vice President of Human Resources, Member of the Management Committee, Member of the Executive Committee

–
MB

Ms. Muriel Barneoud

Group Executive Vice President - CSR And Quality, Member of the Management Committee, Member of the Executive Committee

–
FR

Ms. Frederique Raoult

Group Executive Vice President - Communications, Member of the Management Committee, Member of the Executive Committee

–

Board of Directors

GP

Mr. Guillaume Pepy (67)

Independent Chairman of the Board

296,093.00 EUR
MF

Mrs. Mireille Faugere (68)

Independent Director

56,780.00 EUR
MA

Ms. May Antoun (66)

Director, Employee Representative

968.00 EUR
SD

Mr. Stephane Dedeyan (59)

Director, Representative of CNP Assurances on the Board of Directors

707.00 EUR
PD

Mr. Pascal Demurger (60)

Director, Representative of Mutuelle Assurance Instituteur France

707.00 EUR
SD

Mr. Stephane Dessirier (64)

Director, Representative of MACSF Epargne Retraite

707.00 EUR

Frequently asked questions about Emeis

Analysts currently set an average price target of 13.97 EUR for the Emeis stock (median: 15.81 EUR), implying -3.0 % versus the latest price. The consensus is based on 12 analyst ratings.

Emeis Analyst Price Targets 2026

12 analysts currently rate the Emeis stock: 2 recommend buying, 4 holding and 6 selling. For 2026, analysts expect Emeis to generate revenue of 6.15 B EUR and earnings per share of -0.62 EUR.

Emeis Analyst Price Targets 2026

The Emeis share (EMEIS.PA) is listed on 8 stock exchanges, including: Frankfurt (OPA.F), München (OPA.MU), Düsseldorf (OPA.DU), London (0NEX.L), Wien (ORP.VI), Paris (ORP.PA).

No history available for Emeis.

The expected revenue of Emeis is 6.15 B EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Emeis is -99.29 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Emeis is currently -23.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Emeis stock.

The price-to-sales ratio (P/S) of Emeis is currently 0.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Emeis stock.

The Eulerpool Quality Score for Emeis is 4/10.

The ISIN of Emeis is FR001400NLM4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Emeis is 575626. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Emeis is EMEIS.PA. The ticker symbol is used to trade Emeis shares on the stock exchange.

Over the past 12 months, Emeis paid a dividend of 0.90 EUR . This corresponds to a dividend yield of about 6.25 %. For the coming 12 months, Emeis is expected to pay a dividend of 60.25 EUR.

The current dividend yield of Emeis is 6.25 %.

Emeis pays a dividend, distributed in the months of , , , .

Emeis paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 60.25 EUR are expected. This corresponds to a dividend yield of 418.12 %.

Emeis is assigned to the 'Health' sector.

To receive the latest dividend of Emeis from amounting to 0.9 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Emeis are distributed in EUR.

All fundamentals and in-depth analysis of Emeis

Our stock analysis for Emeis stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Emeis. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Emeis Stock
Emeis Revenue→
Emeis Stock
Emeis Net Income→
Emeis Stock
Emeis P/E→
Emeis Stock
Emeis P/S→
Emeis Stock
Emeis EBIT→
Emeis Stock
Emeis Dividend→
Emeis Stock
Emeis Directors Dealings→
Emeis Stock
Emeis Stocks→
Emeis Stock
Emeis Market capitalization→
Emeis Stock
Emeis Debt→
Emeis Stock
Emeis Liabilities→
Emeis Stock
Emeis Equity→
Emeis Stock
Emeis AAQS→
Emeis Stock
Emeis Employees→
Emeis Stock
Emeis ROE→
Emeis Stock
Emeis ROA→
Emeis Stock
Emeis ROCE→
Emeis Stock
Emeis News→
Emeis Stock
Emeis Analyst Price Targets→

Health Stocks

Emergency Assistance Japan CoEmcure PharmaceuticalsEmergent BioSolutionsEmbracing Future HoldingsEmmaus Life SciencesEmbectaEmmessar Biotech and NutritionEM Systems CoEMV CapitalElutiaEMvision Medical DevicesEloxx PharmaceuticalsAll Stocks A–Z →